Aveanna Healthcare Holdings financials
$12.78+0.71%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jul 4 | Q1 '26 Apr 4 | Q4 '25 Jan 3 | Q3 '25 Sep 27 | Q2 '25 Jun 28 | Q1 '25 Mar 29 | Q4 '24 Dec 28 | Q3 '24 Sep 28 | Q2 '24 Jun 29 | Q1 '24 Mar 30 | Q4 '23 Dec 30 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $670.5M | $647.9M | $662.5M | $621.9M | $589.6M | $559.2M | $519.9M | $509.0M | $505.0M | $490.7M | $478.8M | $478.0M |
| Gross profit | $218.5M | $205.4M | $213.3M | $202.8M | $210.8M | $183.6M | $171.7M | $159.7M | $158.3M | $145.9M | $148.4M | $147.3M |
| Gross margin | 32.6% | 31.7% | 32.2% | 32.6% | 35.8% | 32.8% | 33.0% | 31.4% | 31.3% | 29.7% | 31.0% | 30.8% |
| Operating income | $80.0M | $69.3M | $71.0M | $53.6M | $80.0M | $51.8M | $45.8M | $34.0M | $37.2M | $22.9M | $28.8M | -$75.9M |
| Net income | $40.3M | $41.7M | $178.8M | $14.1M | $27.0M | $5.2M | $29.2M | -$42.8M | $13.9M | -$11.2M | -$25.7M | -$102.4M |
| Net margin | 6.0% | 6.4% | 27.0% | 2.3% | 4.6% | 0.9% | 5.6% | −8.4% | 2.8% | −2.3% | −5.4% | −21.4% |
| Diluted EPS | $0.18 | $0.19 | $0.81 | $0.06 | $0.13 | $0.03 | $0.15 | $-0.22 | $0.07 | $-0.06 | $-0.13 | $-0.54 |
| EBITDA | $87.2M | $75.5M | $75.3M | $55.0M | $86.1M | $54.5M | $49.6M | $36.8M | $40.0M | $25.8M | $32.6M | $32.2M |
| Operating cash flow | $80.9M | $4.3M | $49.7M | $33.2M | $51.6M | -$8.6M | $13.4M | $29.4M | $1.8M | -$12.0M | -$3.0M | $28.7M |
| Free cash flow | $79.6M | -$208.0K | $47.8M | $31.2M | $50.4M | -$11.0M | $11.9M | $27.2M | $540.0K | -$13.3M | -$4.6M | $27.6M |
| Diluted shares | 224.9M | 222.1M | 221.0M | 222.2M | 210.4M | 206.2M | 189.1M | 193.4M | 196.9M | 192.2M | 191.9M | 189.1M |
Balance sheet
| Period end | Jul 4 | Apr 4 | Jan 3 | Sep 27 | Jun 28 | Mar 29 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $97.2M | $189.3M | $193.3M | $145.9M | $100.7M | $71.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.46B | $1.57B | $1.46B | $1.47B | $1.45B | $1.44B |
| Total assets | $2.11B | $2.02B | $2.01B | $1.81B | $1.77B | $1.66B |
| Total liabilities | $1.82B | $1.78B | $1.82B | $1.80B | $1.78B | $1.76B |
| Shareholders' equity | $288.0M | $240.8M | $195.2M | $9.9M | -$11.3M | -$98.7M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology